who medicines strategy - libdoc.who.int - World Health Organization

More documents

Recommendations

Info

WHO MEDICINES STRATEGY 2004-2007 | 110Figure 25:Harmonization activities supported by WHO*••• •*•ASEAN (Association of South East Asian Nations:Brunei, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Thailand, Singapore, VietnamICH (International Conference on Harmonization of Technical Requirements for the Registration of PharmaceuticalsHuman Use): European Union, Japan, USAMERCOSUR (created in 1991 with the signing of the Treaty of Asuncion):Argentina, Brazil, Paraguay, UruguayPANDRA (Pan American Network for Drug Regulatory Harmonization)All the countries of the AmericasSADC (Southern African Development Community): Angola, Botswana, Congo Demoractic Republic, Lesotho, Malawi,Mauritius, Namibia, Mozambique, South Africa, Swaziland, Seychelles, Tanzania, Zambia, ZimbabweUEMOA (Monitory and Economic Union of West Africa)Benin, Burkina Faso, Côte d’Ivoire, Guinea Bissau, Maili, Niger, Senegal, TogoMeeting the challenges 2004-2007Over the next four years WHO will:> continue to promote and monitor networkingand harmonization efforts both regionally andinternationally.> continue to provide technical assistance topromising harmonization initiatives.> increase its capacity to deliver technicalassistance through increased collaboration,partnerships, and alliances with othertechnical organizations such as thePharmaceutical Inspection Co-operationScheme.> continue its observer and/or facilitator rolein international groups on harmonization,including ICH, to ensure that the viewsand needs of all countries are properlyrepresented.OUTCOME INDICATORS1999 2003 2007No. of countries participating in harmonization initiativessupported financially and technically by WHO#REPORTING % TARGET#REPORTING % TARGETna na na 15/191 8% 18%
COMPONENTS OF THE STRATEGY | 111Definition of rational use of medicines“Patients receive medications appropriateto their clinical needs, in doses that meettheir own individual requirements, foran adequate period of time, and at thelowest cost to them and their community.”(WHO, 1985).COMPONENT 7USING MEDICINES RATIONALLY
Page 10 and 11:
WHO MEDICINES STRATEGY 2004-2007 |x
Page 12 and 13:
WHO MEDICINES STRATEGY 2004-2007 |x
Page 14 and 15:
WHO MEDICINES STRATEGY 2004-2007 |
Page 23:
MEDICINESAND PUBLIC HEALTH
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73: WHO MEDICINES STRATEGY 2004-2007 |
Page 157 and 158: REFERENCES
Page 159 and 160: REFERENCES | 1471Annual report 2000
Page 161 and 162: REFERENCES | 14912 th Model List of
show all

who medicines strategy - libdoc.who.int - World Health Organization

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?